| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;59:1405-1407
© 1995 The Society of Thoracic Surgeons
Texas Center for Infectious Disease, San Antonio State Chest Hospital, San Antonio, Texas
 |
Abstract |
|---|
 TopFootnotes Abstract IntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
|
Introduction |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
The current role of surgery in the therapy for Mycobacterium tuberculosis (MTB) is not defined. Medical therapy alone is successful in most patients. Although the introduction of rifampin and short-course chemotherapy has theoretically allowed nearly 100% cure of sensitive disease, tuberculosis has reemerged as an important public health problem [1, 2]. Complacency on the part of health care workers, closing of sanitoriums, the rising incidence of homelessness, intravenous drug abuse, lack of access to health care, immigration, and the human immunodeficiency virus epidemic have led to a dramatic upsurge in the incidence of MTB since 1985 [3]. Many patients fail to complete therapy, thus allowing drug resistance and progressive disease to occur. Pulmonary complications of MTB develop including empyema, bronchopleural fistula, large persistent cavities that may be associated with hemoptysis or secondary infection, bronchiectasis, and pulmonary destruction. Surgical intervention, long neglected, is once again needed to address these problems [4].
|
Material and Methods |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
There were 44 men and 15 women. The mean age was 39 years with a range of 16 to 72 years. There were 38 Hispanics, 10 whites, 8 blacks, and 3 Asians. The indications for operation were as follows: multidrug resistant tuberculosis (MDRTB), 19 patients; bronchopleural fistula, 12; destroyed lung, 7; solitary nodule, 7; hemoptysis, 5; cavity, 4; trapped lung, 3; and empyema, 2.
The most common indication was organisms resistant to multiple drugs. Seventeen of these 19 patients had true multidrug-resistant disease, defined as having organisms resistant to at least isoniazid and rifampin. Two patients had organisms sensitive to isoniazid but resistant to rifampin and other drugs. All 19 patients were operated on as part of their therapeutic regimen. Intensive medical therapy was used in an attempt to convert the results of sputum culture to negative before operation. This effort was successful in 17 patients. Medical regimens were tailored to the individual patient and contained an injectable agent and an average of three oral drugs. In this group of 19 patients, we performed 8 pneumonectomies with latissimus dorsi reinforcement of the bronchial stump, 9 lobectomies, and 2 segmental resections. All surviving patients were followed up postoperatively for at least 12 months. One patient was followed clinically for 12 months and remained well. The others had additional studies comprising chest roentgenography, sputum cul ture, or both. The mean follow-up was 26 months with a range of 12 to 60 months.
The second most common indication was bronchopleural fistula. All 12 patients had a persistent air leak for more than 1 month and were smear and culture positive for MTB sensitive to all drugs on initial examination. Eleven of the 12 patients were initially treated with tube thoracostomy. Thoracostomy tube drainage was continued for 1 month to 4 months and was successful in closing the fistula in 4 patients. The remaining patients required a variety of procedures to effect closure. Definitive surgical therapy was delayed until sputum and pleural fluid cultures were negative. We performed 3 pneumonectomies, 1 window thoracostomy, 2 tailoring thoracoplasties with myoplasty, and 2 decortications.
Destroyed lung tissue and associated symptoms were present in 7 patients. Pneumonectomy was performed on 5 patients who had associated problems including bronchostenosis, recurrent hemoptysis, and persistent drug-sensitive tuberculosis. We performed a segmental resection on 1 patient and a lobectomy with superior segmentectomy on 1.
Seven patients had an undiagnosed lung mass consistent with carcinoma. There were six wedge or segmental resections and one lobectomy performed in this group. We did three lobectomies and two pneumonectomies for recurrent or massive hemoptysis in 5 patients. Three patients with trapped lung underwent decortication. Two patients required drainage of an empyema. One was drained by window thoracostomy and subsequently sterilized with a Clagett procedure. The other patient had drainage of a cold abscess. Four patients had cavities that were large or complicated by superinfection. Two required lobectomy, and 2 underwent wedge resection. Two patients were returned to the operating room for bleeding. Table 1
summarizes the operative procedures performed.
|
|
Results |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
Successful closure was effected in all patients who had bronchopleural fistula. Control of the bleeding was achieved in all 5 patients who underwent operation for massive or recurrent severe hemoptysis. The 7 patients operated on for destroyed lung with symptoms all had successful outcomes. The remaining groups with solitary nodule, cavity, trapped lung, or empyema were successfully treated by a variety of procedures.
Major postoperative complications occurred in 5 patients and included hypoxic encephalopathy in 1, bronchopleural fistula in 2, and return to the operating room for bleeding in 2. Minor complications developed in 7 patients. Four of the major complications were in patients operated on for MDRTB. Postoperative bronchopleural fistula developed in 2 patients. In 1 patient with MDRTB, it responded to tube drainage alone. In the other patient, who underwent emergent pneumonectomy for massive hemoptysis, window thoracostomy and tailoring thoracoplasty were necessary to effect closure. Massive hemoptysis developed in this patient 2 years later and required thoracoplasty and myoplasty for control. The patient is currently well 2 years after the last operation.
Long-term follow-up of our patients who underwent surgical therapy for MTB ranged from 25% to 100%. Long-term follow-up was defined as at least 12 months or to death. This period was chosen because most cases of relapse occur within the first 3 months and in nearly all cases, within the first 6 months [5]. We thought that 12 months would allow us more than adequate time to evaluate the presence of relapse. Follow-up was best in those patients with MDRTB and those with empyema. Most of our patients were judged to be improved at the time of the last follow-up. Details on each group of patients and duration of follow-up are outlined in Table 2.
|
|
Comment |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
Bronchopleural fistula is a devastating complication of tuberculosis. The development of this complication demands prompt drainage. Further treatment depends on the response to drainage, the fistula size, the amount of disease in the lung, the sensitivity of the organisms to first-line drugs, the body's response to the fistula, and other poorly understood factors. A variety of procedures may be necessary to effect closure. Multiple operations are frequently necessary. The institution of definitive surgical therapy should be delayed until control of the tuberculosis infection has been accomplished as evidenced by sputum and pleural fluid conversion to negative on culture. A combination of these approaches was successful in all 12 of our patients.
The natural history of patients with destroyed lungs secondary to tuberculosis has not been defined. We operated on 7 patients with a variety of associated problems including main stem bronchostenosis, repeated bacterial lower respiratory tract infections, fungal balls, and recurrent hemoptysis. All patients in this group had a favorable outcome with amelioration of the problem or symptoms.
On the basis of our experience, we draw several conclusions. (1) Surgery currently plays an important role in the management of MTB. (2) Surgical intervention can be performed with acceptable morbidity and mortality. (3) A variety of procedures are needed to effect cure. (4) Encouraging results in our patients with MDRTB support the use of surgical therapy in this difficult group of patients.
|
Acknowledgments |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
|
Footnotes |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
Address reprint requests to Dr Treasure, 2303 SE Military Dr, San Antonio, TX 78223.
|
References |
|---|
|
TopFootnotesAbstractIntroductionMaterial and MethodsResultsCommentAcknowledgmentsReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  J. G Somocurcio, A. Sotomayor, S. Shin, S. Portilla, M. Valcarcel, D. Guerra, and J. Furin Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Thorax, May 1, 2007; 62(5): 416 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Naidoo Active Pulmonary Tuberculosis: Experience with Resection in 106 Cases Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 134 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Olcmen, M. Z Gunluoglu, A. Demir, H. Akin, H. V Kara, and S. I Dincer Role and Outcome of Surgery for Pulmonary Tuberculosis Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 363 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Kim, C. H. Kang, Y. T. Kim, S-W. Sung, J. H. Kim, S. M. Lee, C-G. Yoo, C-T. Lee, Y. W. Kim, S. K. Han, et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis Eur. Respir. J., September 1, 2006; 28(3): 576 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M Gimferrer and C. A Mestres Role of Surgery in Drug-Resistant Pulmonary Tuberculosis Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 201 - 202. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Olgac, M. A. Yilmaz, M. G. Ortakoylu, and C. A. Kutlu Decision-making for lung resection in patients with empyema and collapsed lung due to tuberculosis J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 131 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Naidoo and A. Reddi Lung Resection for Multidrug-Resistant Tuberculosis Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 172 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Takeda, H. Maeda, M. Hayakawa, N. Sawabata, and R. Maekura Current Surgical Intervention for Pulmonary Tuberculosis Ann. Thorac. Surg., March 1, 2005; 79(3): 959 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Erdogan, A. Yegin, G. Gurses, and A. Demircan Surgical Management of Tuberculosis-Related Hemoptysis Ann. Thorac. Surg., January 1, 2005; 79(1): 299 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shiraishi, Y. Nakajima, N. Katsuragi, M. Kurai, and N. Takahashi Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 523 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Beshay, T. Roth, R. M. Stein, and R. A. Schmid Tuberculosis presenting as pancoast tumor Ann. Thorac. Surg., November 1, 2003; 76(5): 1733 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Connery, J. Knoetgen III, C. E. Anagnostopoulos, and M. V. Svitak Median sternotomy for pneumonectomy in patients with pulmonary complications of tuberculosis Ann. Thorac. Surg., May 1, 2003; 75(5): 1613 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Furak, I. Trojan, T. Szoke, L. Tiszlavicz, Z. Morvay, E. Csada, and A. Balogh Surgical intervention for pulmonary tuberculosis: analysis of indications and perioperative data relating to diagnostic and therapeutic resections Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 722 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Souilamas, M. Riquet, F. Le Pimpec Barthes, A. Chehab, A. Capuani, and E. Faure Surgical treatment of active and sequelar forms of pulmonary tuberculosis Ann. Thorac. Surg., February 1, 2001; 71(2): 443 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-L. Tseng, M.-H. Wu, M.-Y. Lin, and W.-W. Lai Intrathoracic muscle flap transposition in the treatment of fibrocavernous tuberculosis Eur. J. Cardiothorac. Surg., December 1, 2000; 18(6): 666 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Al-Kattan Management of tuberculous empyema Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 251 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Sung, C. H. Kang, Y. T. Kim, S. K. Han, Y.-S. Shim, and J. H. Kim Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Halezeroglu, M. Keles, A. Uysal, M. Celik, C. Senol, G. Haciibrahimoglu, and B. Arman Factors Affecting Postoperative Morbidity and Mortality in Destroyed Lung Ann. Thorac. Surg., December 1, 1997; 64(6): 1635 - 1638. [Abstract] [Full Text]
|
|
|
|
|
|
M. Van Leuven, M. De Groot, K. P. Shean, U. O. Von Oppell, and P. A. Willcox Pulmonary Resection as an Adjunct in the Treatment of Multiple Drug-Resistant Tuberculosis Ann. Thorac. Surg., May 1, 1997; 63(5): 1368 - 1372. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. JOUVESHOMME, B. DAUTZENBERG, H. BAKDACH, and J.-P. DERENNE Preliminary Results of Collapse Therapy with Plombage for Pulmonary Disease Caused by Multidrug-resistant Mycobacteria Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1609 - 1615. [Abstract] [Full Text]
|
|
|
|
|
|
G. Massard, A. Dabbagh, J.-M. Wihlm, R. Kessler, P. Barsotti, N. Roeslin, and G. Morand Pneumonectomy for Chronic Infection Is a High-Risk Procedure Ann. Thorac. Surg., October 1, 1996; 62(4): 1033 - 1037. [Abstract] [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
